A phase II trial of KX2-391 in patients with acute myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2012
At a glance
- Drugs KX 01 (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Athenex
- 05 Dec 2012 Planned initiation date changed from 1 Dec 2011 to unknown.
- 26 Apr 2011 New trial record